---
$id: https://graph.org.ai/products/commodity/51201808
$type: Product
source: UNSPSC
code: "51201808"
title: "Levamisole or tetramisole"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levamisole or tetramisole

**UNSPSC Code**: 51201808
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a chemo immunostimulant adjuvant with the molecular formula C11H12N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2880D3468G, chemically known as l-2,3,5,6-tetrahyro-6-phenylimidazo(2,1-b)thiazole but generally known as levamisole, which bears US NIH Compound Identifier 26879. European Medicines Agency schedules Levamisole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08454MIG. The term LEVAMISOLE is an International Non-Proprietary Name. World Health Organization schedules levamisole in its Anatomical Therapeutic Chemical (ATC) Classification. LEVAMISOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Levamisole or tetramisole bears US NLM identifiers UMLS ID C0023556 and NCI Concept Code C61609. SMILES: C1CSC2=NC(CN21)C3=CC=CC=C3.

